Hydrochlorothiazide and Indapamide bind the NADPH binding site of bacterial Dihydrofolate Reductase: results of an in-silico study and their implications


Hypertension is a public health concern. Low dose thiazide diuretics are known to effectively control blood pressure compared to that of other classes of antihypertensive drugs. In this context, we have performed an in-silico study and found that the two Sulphonamide Diuretics Hydrochlorothiazide and Indapamide bound the NADPH binding region of bacterial Dihydrofolate Reductase. Therefore, akin to Sulphonamide Antibiotics, Sulphonamide Diuretics may have antibiotic activity and thereby have the potential to modulate the gut microbiome in a way beneficial to vascular health. The in-silico experiment results were analyzed in the context of the relevant literature. We postulate that Sulphonamide Diuretics exert their antihypertensive role by modulating the gut microbiome, specifically by increasing butyrate-producing taxa in the gut. We recommend extending such work as it is plausible that Indapamide and other Sulphonamide Diuretics may be beneficial for both diabetes and hypertension.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6


  1. Abraham MJ, van der Spoel D, Lindahl E, Hess B, and the GROMACS development team (2018) GROMACS User Manual version 2018.4. http://www.gromacs.org/. Accessed 4 Nov 2020

  2. Adnan S, Nelson JW, Ajami NJ et al (2017) Alterations in the gut microbiota can elicit hypertension in rats. Physiol Genom 49:96–104

    CAS  Article  Google Scholar 

  3. Arima H, Barzi F, Chalmers J (2011) Mortality patterns in hypertension. J Hypertens 29:S3–S7

    CAS  Article  Google Scholar 

  4. Borg MJ, Jones KL, Sun Z et al (2019) Metformin attenuates the postprandial fall in blood pressure in type 2 diabetes. Diabetes Obes Metab 21:1251–1254

    CAS  Article  Google Scholar 

  5. Cao H, Gao M, Zhou H et al (2018) The crystal structure of a tetrahydrofolate-bound dihydrofolate reductase reveals the origin of slow product release. Commun Biol 1:226

    CAS  Article  Google Scholar 

  6. Delano WL (2020) The pymol molecular graphics system. http://www.pymol.org [Internet]. [cited 2020 Sep 21]. https://ci.nii.ac.jp/naid/10020095229/. Accessed 4 Nov 2020

  7. Elliott WJ, Weber RR, Murphy MB (1991) A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J Clin Pharmacol 31:751–757

    CAS  Article  Google Scholar 

  8. Escobar E (2002) Hypertension and coronary heart disease. J Hum Hypertens 16:S61–S63

    Article  Google Scholar 

  9. Gabel SA, Duff MR, Pedersen LC, DeRose EF, Krahn JM, Howell EE et al (2017) A structural basis for biguanide activity. Biochemistry. Sep 12;56(36):4786–98

  10. Inaba M, Noguchi Y, Yamamoto T et al (2004) Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. Hypertens Res 27:141–145

    CAS  Article  Google Scholar 

  11. Kuo S-W, Pei-Dee, Hung Y-J et al (2003) Effect of indapamide SR in the treatment of hypertensive patients with type 2 diabetes. Am J Hypertens 16:623–628

    CAS  Article  Google Scholar 

  12. Landin-Wilhelmsen K (1992) Metformin and blood pressure. J Clin Pharm Ther 17:75–79

    CAS  Article  Google Scholar 

  13. MacKerell AD Jr, Brooks B, Brooks CL III, Nilsson L, Roux B, Won Y, Karplus M (1998) CHARMM: the energy function and its parameterization. In: Schleyer PVR, Allinger NL, Clark T, Gasteiger J, Kollman PA, Schaefer HF III, Schreiner PR (eds) Encyclopedia of computational chemistry. Wiley, Chichester, pp 271–277

    Google Scholar 

  14. Maniar K, Moideen A, Mittal A et al (2017) A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: genesis of a wonder drug? Pharmacol Res 117:103–128

    CAS  Article  Google Scholar 

  15. Majithiya JB, Balaraman R (2006) Metformin reduces blood pressure and restores endothelial function in aorta of streptozotocin-induced diabetic rats. Life Sci 78:2615–2624

    CAS  Article  Google Scholar 

  16. McAdams DeMarco MA, Maynard JW, Baer AN et al (2012) Diuretic use, increased serum urate levels, and risk of incident gout in a population-based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study. Arthritis Rheum 64:121–129

    CAS  Article  Google Scholar 

  17. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity. J Comput Chem 16:2785–91

    Article  Google Scholar 

  18. Mortensen FV, Nielsen H, Mulvany MJ et al (1990) Short chain fatty acids dilate isolated human colonic resistance arteries. Gut 31:1391–1394

    CAS  Article  Google Scholar 

  19. Muntzel MS, Hamidou I, Barrett S (1999) Metformin attenuates salt-induced hypertension in spontaneously hypertensive rats. Hypertension 33:1135–1140

    CAS  Article  Google Scholar 

  20. Pluznick JL (2017) Microbial short chain fatty acids and blood pressure regulation. Curr Hypertens Rep 19:25

    Article  Google Scholar 

  21. Qi Y, Aranda JM, Rodriguez V et al (2015) Impact of antibiotics on arterial blood pressure in a patient with resistant hypertension—a case report. Int J Cardiol 201:157–158

    Article  Google Scholar 

  22. Raja R, Kavita F, Amreek F et al (2019) Hyperuricemia associated with thiazide diuretics in hypertensive adults. Cureus 11(8):e5457. https://doi.org/10.7759/cureus.5457

    Article  PubMed  PubMed Central  Google Scholar 

  23. Roush GC, Sica DA (2016) Diuretics for hypertension: a review and update. AJHYPE 29:1130–1137

    CAS  Article  Google Scholar 

  24. Reeves DS, Bint AJ, Bullock DW (1978) Use of antibiotics. Sulphonamides, co-trimoxazole, and tetracyclines. BMJ 2:410–413

    CAS  Article  Google Scholar 

  25. Sawaya MR, Kraut J (1997) Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry 36:586–603

    CAS  Article  Google Scholar 

  26. Scriabine A (2007) 6.32—hypertension. In: Taylor JB, Triggle DJ (eds) Comprehensive medicinal chemistry II. Elsevier, Oxford, pp 705–728

    Google Scholar 

  27. Sharabi Y, Grossman E, Nussinovitch N et al (1996) Indapamide—a substitute diuretic for hypertensives with hyperglycemia and/or dyslipidemia. Harefuah 131:233–236

    CAS  PubMed  Google Scholar 

  28. Turner PJ, Grace XM (2005) Version 5.1.19. Center for coastal and land-margin research. Oregon Graduate Institute of Science and Technology, Beaverton

    Google Scholar 

  29. Vallianou NG, Stratigou T, Tsagarakis S (2019) Metformin and gut microbiota: their interactions and their impact on diabetes. Hormones (Athens) 18:141–144

    Article  Google Scholar 

  30. Wood WB (1942) Studies on the antibacterial action of the sulfonamide drugs. J Exp Med 75:369–381

    CAS  Article  Google Scholar 

  31. Wulffelé MG, Kooy A, Lehert P et al (2005) Does metformin decrease blood pressure in patients with Type 2 diabetes intensively treated with insulin? Diabetics Med 22:907–913

    Article  Google Scholar 

  32. Yang T, Santisteban MM, Rodriguez V et al (2015) Gut dysbiosis is linked to hypertension. Hypertension 65:1331–1340

    CAS  Article  Google Scholar 

  33. Zhang X, Zhao Q (2016) Association of thiazide-type diuretics with glycemic changes inhypertensive patients: a systematic review and meta-analysis of randomizedcontrolled clinical trials. J Clin Hypertens (Greenwich) 18:342–351

    CAS  Article  Google Scholar 

  34. Zoete V, Cuendet MA, Grosdidier A, Michielin O (2011) SwissParam, a fast force field generation tool for small organic molecules. J Comput Chem 32(11):2359–68. https://doi.org/10.1002/jcc.21816 (PMID: 21541964)

    CAS  Article  PubMed  Google Scholar 

Download references


SK and DB acknowledge PGIMER, Chandigarh for providing financial assistance vide Endst No. PGI/MERC/2020/4655-58 dated 7.10.2019 (Collectively) and No. 71/2-Edu-16/415 dated 23.1.2019.

Author information



Corresponding authors

Correspondence to Rajasri Bhattacharyya or Dibyajyoti Banerjee.

Ethics declarations

Conflict of interest

The authors declares that they have no competing interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kaur, S., Bhattacharyya, R. & Banerjee, D. Hydrochlorothiazide and Indapamide bind the NADPH binding site of bacterial Dihydrofolate Reductase: results of an in-silico study and their implications. In Silico Pharmacol. 8, 5 (2020). https://doi.org/10.1007/s40203-020-00056-9

Download citation


  • Hypertension
  • Diuretics
  • Thiazide
  • Sulphonamide
  • Antibiotics
  • Gut microbiome
  • Diabetes mellitus